From EGottlieb at cityofithaca.org Tue Sep 1 14:28:33 2015 From: EGottlieb at cityofithaca.org (Ed Gottlieb) Date: Tue Sep 1 14:28:47 2015 Subject: [Pharmwaste] FDA adding reseacher to guide research/regulation of drugs w/ Estrogenic, Androgenic, or Thyroid Activity Message-ID: <65AC0C9A3A6A474EAD8D56070FED66986DE60463@MAIL.cityofithaca.org> http://orise.orau.gov/science-education/internships-scholarships-fellowships/description.aspx?JobId=18495 The National Environmental Policy Act of 1969 (NEPA) requires all Federal agencies to assess the environmental impact of their actions. To comply, FDA implements 21 CFR Part 25, which includes a requirement for an environmental assessment (EA) if ?extraordinary circumstances? indicate that the specific proposed action may significantly affect the quality of the human environment. The new EA draft guidence, Questions and Answers Regarding Drugs With Estrogenic, Androgenic, or Thyroid Activity, informs drug applicants that recent research indicates that some drugs with hormonal activity in the environment may exhibit ?extraordinary circumstances? and that the Agency may require additional ecotoxicity testing for applications submitted for drugs with hormonal activity. In addition, antimicrobial, additivity/synergism, nanotechnology, and other properties have been implicated for possible adverse environment effects, as well as human effects through environmental pathways. Also, other Centers (e.g., CVM), agencies (e.g., EPA), and regions (e.g., EU) have begun addressing these issues through research, guidance, and regulatory development. The EA Staff requires support for research and implementation to address these issues. Rhetorically, I wonder how big the FDA research staff is that they are only adding one temporary position to help cover the huge range of tasks spelled out in the job announcement (link above)? Who would take on such a daunting task, knowing they have to do it in only one year? And, as a consultant, they have to provide their own health insurance. Ed Gottlieb Chair, Coalition for Safe Medication Disposal Industrial Pretreatment Coordinator Ithaca Area Wastewater Treatment Facility 525 3rd Street Ithaca, NY 14850 (607) 273-8381 fax: (607) 273-8433 -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150901/188d08f7/attachment.html From James.Laurenson at fda.hhs.gov Thu Sep 3 10:52:03 2015 From: James.Laurenson at fda.hhs.gov (Laurenson, James) Date: Thu Sep 3 10:55:11 2015 Subject: [Pharmwaste] FDA adding reseacher to guide research/regulation of drugs w/ Estrogenic, Androgenic, or Thyroid Activity In-Reply-To: <65AC0C9A3A6A474EAD8D56070FED66986DE60463@MAIL.cityofithaca.org> References: <65AC0C9A3A6A474EAD8D56070FED66986DE60463@MAIL.cityofithaca.org> Message-ID: <8C393F82878AD64AAA267CD0CCE4F49D53B161CE@FDSWV09435.fda.gov> Thanks Ed for advertising this! And, while rhetorical, you raise some good questions about the scope of the fellowship (and about us maybe needing more staff...or pay! :) ). A key clarification is that the participant would not be guiding the research/regulation of drugs w/E, A, or T activity or the other topics noted. Rather, the appointment is an educational opportunity, as described more at http://orise.orau.gov/fda/current-research-participant/nature-of-appointment.htm, which would involve working with CDER staff as well as with other FDA Centers and other agencies on a variety of research topics, with EAT activity the main focus given the new draft guidance. Regarding the one year appointment, this is routine for ORISE. They can be extended in increments of up to one year, up to a total of four (postgrad.) or five (postdoc.) years, contingent upon project needs and funding. See "How to renew a participant" in the sidebar of the above link. And yes, health insurance is required, but it can be purchased through ORISE at reasonable rates (see "Insurance" at the link above). If anyone has any questions about the position, please let me know. Best, Jim James Laurenson / Environmental Officer, Toxicologist / Center for Drug Evaluation & Research / U.S. Food & Drug Administration / 10903 New Hampshire Ave., Bldg. 21, Rm. 1626 / Silver Spring, MD 20993 / 301-796-4872 (office) / 703-342-9496 (cell) / james.laurenson@fda.hhs.gov From: pharmwaste-bounces@lists.dep.state.fl.us [mailto:pharmwaste-bounces@lists.dep.state.fl.us] On Behalf Of Ed Gottlieb Sent: Tuesday, September 01, 2015 2:29 PM To: pharmwaste@lists.dep.state.fl.us Subject: [Pharmwaste] FDA adding reseacher to guide research/regulation of drugs w/ Estrogenic, Androgenic, or Thyroid Activity http://orise.orau.gov/science-education/internships-scholarships-fellowships/description.aspx?JobId=18495 The National Environmental Policy Act of 1969 (NEPA) requires all Federal agencies to assess the environmental impact of their actions. To comply, FDA implements 21 CFR Part 25, which includes a requirement for an environmental assessment (EA) if "extraordinary circumstances" indicate that the specific proposed action may significantly affect the quality of the human environment. The new EA draft guidence, Questions and Answers Regarding Drugs With Estrogenic, Androgenic, or Thyroid Activity, informs drug applicants that recent research indicates that some drugs with hormonal activity in the environment may exhibit "extraordinary circumstances" and that the Agency may require additional ecotoxicity testing for applications submitted for drugs with hormonal activity. In addition, antimicrobial, additivity/synergism, nanotechnology, and other properties have been implicated for possible adverse environment effects, as well as human effects through environmental pathways. Also, other Centers (e.g., CVM), agencies (e.g., EPA), and regions (e.g., EU) have begun addressing these issues through research, guidance, and regulatory development. The EA Staff requires support for research and implementation to address these issues. Rhetorically, I wonder how big the FDA research staff is that they are only adding one temporary position to help cover the huge range of tasks spelled out in the job announcement (link above)? Who would take on such a daunting task, knowing they have to do it in only one year? And, as a consultant, they have to provide their own health insurance. Ed Gottlieb Chair, Coalition for Safe Medication Disposal Industrial Pretreatment Coordinator Ithaca Area Wastewater Treatment Facility 525 3rd Street Ithaca, NY 14850 (607) 273-8381 fax: (607) 273-8433 -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150903/b2ce9596/attachment.htm From Laurie.Tenace at dep.state.fl.us Fri Sep 4 09:48:07 2015 From: Laurie.Tenace at dep.state.fl.us (Tenace, Laurie) Date: Fri Sep 4 09:48:32 2015 Subject: [Pharmwaste] FW: drug buster, dug dispose all' In-Reply-To: References: Message-ID: Please note that this email did not originate with me. Please respond to Linda.Birmingham@des.nh.gov Thanks, Laurie From: Birmingham, Linda [mailto:Linda.Birmingham@des.nh.gov] Sent: Wednesday, September 02, 2015 11:11 AM To: pharmwaste@lists.dep.state.fl.us Subject: drug buster, dug dispose all' Would appreciate any comments on these two drug disposal systems. I know this has come up before but now they have been in discussions with some of our NH hospitals. Wondering if any States have approved or not approved of their use and why. I have attached facts sheets for both. Thanks, Linda Linda R. Birmingham, CHMM, CPM Permit Engineer N.H. DES 29 Hazen Drive Concord, NH 03302 Tel: (603) 271-5328 Fax (603) 271-2456 E-mail: Linda.Birmingham@des.nh.gov This E-mail and any files transmitted with it are confidential and are intended solely for the use of the individual or entity to whom they are addressed. This communication may contain material protected by law or regulation. If you are not the intended recipient or the person responsible for delivering the E-mail for the intended recipient, be advised that you have received this E-mail in error and that any use, dissemination, forwarding, printing, or copying of this E-mail is strictly prohibited. If you believe that you have received this E-mail in error, please notify me at the Department of Environmental Services at (603) 271-5328. -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150904/27ea2852/attachment.htm -------------- next part -------------- A non-text attachment was scrubbed... Name: image001.gif Type: image/gif Size: 2051 bytes Desc: image001.gif Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150904/27ea2852/image001-0001.gif -------------- next part -------------- A non-text attachment was scrubbed... Name: Disposal Technologies_DrugDisposeAll_APR2015.pdf Type: application/pdf Size: 598526 bytes Desc: Disposal Technologies_DrugDisposeAll_APR2015.pdf Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150904/27ea2852/DisposalTechnologies_DrugDisposeAll_APR2015-0001.pdf -------------- next part -------------- A non-text attachment was scrubbed... Name: Drug Buster Marketing Launch Final.pdf Type: application/pdf Size: 175465 bytes Desc: Drug Buster Marketing Launch Final.pdf Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150904/27ea2852/DrugBusterMarketingLaunchFinal-0001.pdf From EGottlieb at cityofithaca.org Fri Sep 4 10:50:05 2015 From: EGottlieb at cityofithaca.org (Ed Gottlieb) Date: Fri Sep 4 10:53:00 2015 Subject: [Pharmwaste] RE: drug buster, drug dispose all Message-ID: <65AC0C9A3A6A474EAD8D56070FED66986DE62835@MAIL.cityofithaca.org> Hi Linda, Though not directly addressing your question, you may be interested to see a list of disposal products and their claims, including the two you asked about: https://docs.google.com/spreadsheets/d/1HSp0xej53KO0MkZ4f950BI-Hn2Bl-fD_QF54JHr35hU/edit?usp=sharing It is my understanding that if RICA listed hazardous wastes are put in a disposal unit by a hospital the contents would have to be disposed of as hazardous waste unless testing showed it is no longer hazardous or they qualify as a conditionally exempt small quantity generator. I have not seen evidence that any government agency has endorsed activated carbon or bentonite clay based disposal products as acceptable in meeting the DEA non-recoverable, or any other disposal standard. I also have not seen evidence that any government agency has challenged the claims made for products using these materials. Portable incinerators have run into issues regarding their air emissions. If you receive any off-list replies addressing state approval/non-approval, please pass them on. Thank you. Ed Gottlieb Chair, Coalition for Safe Medication Disposal Industrial Pretreatment Coordinator Ithaca Area Wastewater Treatment Facility 525 3rd Street Ithaca, NY 14850 (607) 273-8381 fax: (607) 273-8433 ________________________________ From: pharmwaste-bounces@lists.dep.state.fl.us [pharmwaste-bounces@lists.dep.state.fl.us] on behalf of Tenace, Laurie [Laurie.Tenace@dep.state.fl.us] Sent: Friday, September 04, 2015 9:48 AM To: pharmwaste@lists.dep.state.fl.us Subject: [Pharmwaste] FW: drug buster, dug dispose all' Please note that this email did not originate with me. Please respond to Linda.Birmingham@des.nh.gov Thanks, Laurie From: Birmingham, Linda [mailto:Linda.Birmingham@des.nh.gov] Sent: Wednesday, September 02, 2015 11:11 AM To: pharmwaste@lists.dep.state.fl.us Subject: drug buster, dug dispose all' Would appreciate any comments on these two drug disposal systems. I know this has come up before but now they have been in discussions with some of our NH hospitals. Wondering if any States have approved or not approved of their use and why. I have attached facts sheets for both. Thanks, Linda Linda R. Birmingham, CHMM, CPM Permit Engineer N.H. DES 29 Hazen Drive Concord, NH 03302 Tel: (603) 271-5328 Fax (603) 271-2456 E-mail: Linda.Birmingham@des.nh.gov This E-mail and any files transmitted with it are confidential and are intended solely for the use of the individual or entity to whom they are addressed. This communication may contain material protected by law or regulation. If you are not the intended recipient or the person responsible for delivering the E-mail for the intended recipient, be advised that you have received this E-mail in error and that any use, dissemination, forwarding, printing, or copying of this E-mail is strictly prohibited. If you believe that you have received this E-mail in error, please notify me at the Department of Environmental Services at (603) 271-5328. -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150904/1bbe29e1/attachment.htm -------------- next part -------------- A non-text attachment was scrubbed... Name: image001.gif Type: image/gif Size: 2051 bytes Desc: image001.gif Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150904/1bbe29e1/image001.gif From Jeanie.Jaramillo at ttuhsc.edu Fri Sep 4 13:45:42 2015 From: Jeanie.Jaramillo at ttuhsc.edu (Jaramillo, Jeanie) Date: Fri Sep 4 13:46:08 2015 Subject: [Pharmwaste] Installing RxReturn Box Message-ID: <89794C5282FE3149A068A7A5111C0DB0A677DD7E@lubmb01.ttuhsc.edu> Hello Group, As you all may or may not know, our poison center conducts community medication take back events in collaboration with local law enforcement twice per year in Abilene, Amarillo, and Lubbock, Texas. We are actually conducting events #39, 40, and 41 on Sept. 12, Oct. 3, and Oct. 17. Our affiliation with Texas Tech School of Pharmacy provides us an excellent opportunity to combine our community service program with a research initiative as well, while also utilizing pharmacy students (who have had background checks) as volunteers. We are also fortunate in our community in that both of our sheriff's departments have permanent drop boxes available to the public. However, as many of us know, not everyone will go to a law enforcement establishment for med disposal. So, to add to the arsenal of med disposal options in our community, our poison center has partnered with our University's pharmaceutical care center (i.e. pharmacy) to install a RxReturn Box (http://www.rxreturnbox.com/) from RedBag Service. One of the factors that led us to select this product over a competitor was the option for a one-year contract. With funding never being assured on a long-term basis, and not know how this service will be received by the public, and/or how it will work out at the pharmacy, the shorter-term contract was a nice option for us. They've also been wonderful to work with. And, I am not being paid by RedBag to state this. We're going to be logging our experience (after all we log everything else, right!) so we can share the ups and downs. It appears from the DEA website that this receptacle will be the only one within a 50 mile radius of our area. I'll keep you all updated regarding how it goes! Jeanie Jaramillo-Stametz, PharmD Managing Director, Texas Panhandle Poison Center Asst. Professor, Texas Tech UHSC School of Pharmacy Director, Medication Cleanout 1300 S. Coulter St., Suite 105 Amarillo, TX 79106 (office): (806)414-9299 (mobile): (806)376-0039 -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150904/a9466fe9/attachment.htm From Deborah.DeBiasi at deq.virginia.gov Wed Sep 9 09:35:30 2015 From: Deborah.DeBiasi at deq.virginia.gov (DeBiasi, Deborah (DEQ)) Date: Wed Sep 9 09:36:19 2015 Subject: [Pharmwaste] Aeration May Remove SSRIs (selective serotonin reuptake inhibitors, generally used as antidepressants) From Landfill Leachate Message-ID: <2FB366A29AAF0D47BD422C53F698353F45AE87EE@COVMSGCES-MBX02> http://www.environmentalleader.com/2015/08/10/aeration-may-remove-ssris-from-landfill-leachate/ August 10, 2015 Aeration May Remove SSRIs From Landfill Leachate [Aeration treatment may be an effective means of removing selective serotonin reuptake inhibitors (SSRIs) from landfill leachate before they reach the environment, a new study finds.] Related Stories How to Treat Landfill Leachate Wastewater Aeration to Reach $8.4 Billion by 2020 Landfill Consultant Uses Analyzer to Improve Gas Management Techniques Aeration treatment may be an effective means of removing selective serotonin reuptake inhibitors (SSRIs) from landfill leachate before they reach the environment, a new study finds. SSRIs, generally used as antidepressants, are often not fully metabolized in the human body. When excreted, these drugs can end up in municipal sewage systems and landfill leachate. If the leachate enters the groundwater, the drug compounds can be released into the environment and have negative impacts on other living organisms. A team of Norwegian researchers set out to gain a better understanding of what happens to these compounds during aeration, and whether they can be removed before leachates enter the environment. Aeration is used to purify the liquid within a pond or lagoon before it is released into the environment. However, not all pharmaceuticals react in the same way to aeration, and its effects on SSRIs within landfill leachate is poorly understood. Over a five-day period, the researchers mimicked the process used to treat landfill leachate using samples containing five different SSRIs - citalopram, fluoxetine, paroxetine, sertraline and fluvoxamine - and three of their metabolites. The concentration of the SSRIs in water samples was measured at the beginning and the end of the study period and compared to the total amount of SSRIs that would be present if no reduction had occurred. In all of the samples, the concentration of the SSRIs was reduced by more than 80 percent. Fluvoxamine and citalopram were removed entirely from both high- and low-concentration samples. The samples were also tested for their known metabolites, the compounds produced when these SSRIs are broken down in the body. Only one could be detected, suggesting that aeration may break down the compounds differently than human metabolism. The results of such studies could inform more sophisticated water treatment systems to prevent the negative environmental impact of pharmaceutical pollution. Deborah L. DeBiasi Email: Deborah.DeBiasi@deq.virginia.gov WEB site address: www.deq.virginia.gov Virginia Department of Environmental Quality Office of Water Permits Industrial Pretreatment/Whole Effluent Toxicity (WET) Program PPCPs, EDCs, and Microconstituents http://www.deq.virginia.gov/Programs/Water/PermittingCompliance/PollutionDischargeElimination/Microconstituents.aspx Mail: P.O. Box 1105, Richmond, VA 23218 Location: 629 E. Main Street, Richmond, VA 23219 PH: 804-698-4028 FAX: 804-698-4032 -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150909/8242f38c/attachment.html -------------- next part -------------- A non-text attachment was scrubbed... Name: image001.jpg Type: image/jpeg Size: 9387 bytes Desc: image001.jpg Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150909/8242f38c/image001.jpg From Deborah.DeBiasi at deq.virginia.gov Wed Sep 9 09:45:02 2015 From: Deborah.DeBiasi at deq.virginia.gov (DeBiasi, Deborah (DEQ)) Date: Wed Sep 9 09:58:14 2015 Subject: [Pharmwaste] Pharmaceuticals in wastewater target of sewage treatment study Message-ID: <2FB366A29AAF0D47BD422C53F698353F45AE881B@COVMSGCES-MBX02> http://www.cbc.ca/news/canada/nova-scotia/pharmaceuticals-in-wastewater-target-of-sewage-treatment-study-1.3155804?utm_source=Canadian+Green+Health+Care+Digest+153&utm_campaign=Digest+153&utm_medium=email Pharmaceuticals in wastewater target of sewage treatment study Studies show some pharmaceuticals can harm fish, but effects on humans still not clear CBC News Posted: Jul 17, 2015 6:00 AM AT Last Updated: Jul 17, 2015 6:00 AM AT [Acadia University chemist Anthony Tong demonstrates how his membrane bioreactor works. Testing will soon begin to see if the device can eliminate pharmaceuticals from waste water.] Acadia University chemist Anthony Tong demonstrates how his membrane bioreactor works. Testing will soon begin to see if the device can eliminate pharmaceuticals from waste water. (CBC) Related Stories * Experimental Lakes study finds damage from birth control pills * Drinking water contaminated by excreted drugs a growing concern * Antidepressants in Montreal waste water It looks a bit like something that was cobbled together with stuff found in the basement. Two small tanks, a hodgepodge of pipes and some dirty tubes that make up the membrane. But scientists at Acadia University hope this bioreactor is the solution to an emerging question: how to stop traces of medications swallowed by Canadians and excreted into toilets from slipping through wastewater treatment plants and into streams, rivers and lakes. * Drinking water contaminated by excreted drugs a growing concern * Experimental Lakes study finds damage from birth control pills "The municipal wastewater plant, they're not designed to treat the pharmaceuticals," says Anthony Tong, a professor of chemistry at the university. "That is the major concern here." Tong and his team will soon begin testing the device and the special membrane that's been devised, an effort that throws traditional sewage treatment methods for a loop. Rather than kill bacteria in sewage water, researchers are looking to pinpoint particular strains that can be effective in breaking down pharmaceuticals. The membrane will hold on to those bacteria, using what's already in the wastewater to clean out contaminants. "It's doable," Tong says. "It's more of a how and when we are going to implement a new technology to improve the pharmaceutical treatment efficiency." Pharmaceuticals end up in wastewater because drugs are not completely metabolised. In some cases, as much as 90 per cent passes through our bodies. N.S. waste water tested In recent years, Acadia researchers have sampled water leaving more than 20 sewage treatment plants across Nova Scotia, testing each for 13 commonly used pharmaceuticals and finding traces of all. The list includes drugs to treat diabetes, inflammation and depression, and household staples like acetaminophen. Scientists also looked at caffeine and cotinine, which is found in tobacco. The levels of pharmaceuticals in samples varied greatly, Tong said, depending in part on the level of treatment the water received. The chemist's aim is to improve on that, creating a system that can be easily added to sewage plants to specifically target pharmaceuticals. The work adds to an emerging body of research examining pharmaceuticals that are going down household toilets and eventually emerging in the environment. Tong says most of the samples he and his team tested revealed only trace amounts, not enough to have an "acute toxic effect." The worry, he says, is bioaccumulation - pharmaceuticals building up in tissue over time and making their way up through the food chain. Aquatic harm The amounts detected in other studies are generally small and it's not clear what effect, if any at all, this might have on humans. But scientists have shown some pharmaceuticals can harm aquatic reproduction. Last year, Environment Canada officials told a Senate committee hearing that more than 165 individual pharmaceuticals and personal care products have been identified in water samples. The difficulty in determining wider implications is that wastewater treatment plants are all different and the "cocktail" of pharmaceuticals that come through them vary, says Wendy Krkosek, a research engineer with Dalhousie University's Centre for Water Resources Studies. The ongoing research is being monitored by Halifax Water, which runs several wastewater treatment plants in the metro area. Susheel Arora, director of waste water services, says sewage plants are generally not designed to remove pharmaceuticals, but some are still eliminated through regular treatment. He says some ecotoxicity studies show changes in fish, but scientists are still looking at the effects of miniscule concentrations. "That's where the research is going," Arora says. "What is the risk? That's the billion dollar question. What is the risk of these things at those certain low levels." There are currently no national standards specifically governing the treatment of pharmaceuticals in wastewater. And Arora says he believes it will be a "long time" before sewage plants are required to filter out such contaminants. Deborah L. DeBiasi Email: Deborah.DeBiasi@deq.virginia.gov WEB site address: www.deq.virginia.gov Virginia Department of Environmental Quality Office of Water Permits Industrial Pretreatment/Whole Effluent Toxicity (WET) Program PPCPs, EDCs, and Microconstituents http://www.deq.virginia.gov/Programs/Water/PermittingCompliance/PollutionDischargeElimination/Microconstituents.aspx Mail: P.O. Box 1105, Richmond, VA 23218 Location: 629 E. Main Street, Richmond, VA 23219 PH: 804-698-4028 FAX: 804-698-4032 -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150909/d06486d9/attachment-0001.htm -------------- next part -------------- A non-text attachment was scrubbed... Name: image001.jpg Type: image/jpeg Size: 14369 bytes Desc: image001.jpg Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150909/d06486d9/image001-0001.jpg From jennifer.volkman at state.mn.us Wed Sep 9 13:05:24 2015 From: jennifer.volkman at state.mn.us (Volkman, Jennifer (MPCA)) Date: Wed Sep 9 13:06:09 2015 Subject: [Pharmwaste] FW: Need for HW Rx Disposal Confirmation In-Reply-To: <753D17F3DCCC8D42BF0804DA95859B2E4D889A@055-CH1MPN1-001.055d.mgd.msft.net> References: <753D17F3DCCC8D42BF0804DA95859B2E4D889A@055-CH1MPN1-001.055d.mgd.msft.net> Message-ID: It doesn't happen very often, but one of the reasons that requiring pharmaceutical disposal confirmation can be important instead of just accepting statements that they 'sent it back' (to a black box): http://www.wzzm13.com/story/news/2015/08/27/kentwood-pharmacy-fraud/71278346/ -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150909/ba0a55b8/attachment.html From GILLIAM at adeq.state.ar.us Wed Sep 9 13:15:07 2015 From: GILLIAM at adeq.state.ar.us (Gilliam, Allen) Date: Wed Sep 9 13:13:18 2015 Subject: [Pharmwaste] RE: Need for HW Rx Disposal Confirmation In-Reply-To: References: <753D17F3DCCC8D42BF0804DA95859B2E4D889A@055-CH1MPN1-001.055d.mgd.msft.net> Message-ID: Lawzy JV! And this is just one they caught! There's probably 100s of pharmacies "out there" doing the same thing. From: pharmwaste-bounces@lists.dep.state.fl.us [mailto:pharmwaste-bounces@lists.dep.state.fl.us] On Behalf Of Volkman, Jennifer (MPCA) Sent: Wednesday, September 09, 2015 12:05 PM To: Pharmwaste list serve Subject: [Pharmwaste] FW: Need for HW Rx Disposal Confirmation It doesn't happen very often, but one of the reasons that requiring pharmaceutical disposal confirmation can be important instead of just accepting statements that they 'sent it back' (to a black box): http://www.wzzm13.com/story/news/2015/08/27/kentwood-pharmacy-fraud/71278346/ -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150909/43d4a931/attachment.htm From Suzy at productstewardship.us Fri Sep 11 13:51:09 2015 From: Suzy at productstewardship.us (Suzy Whalen) Date: Fri Sep 11 13:54:16 2015 Subject: [Pharmwaste] Free Webinar | "A Quest for Convenience: Drug Take-Back at Retail Pharmacies" Message-ID: Good afternoon, The Product Stewardship Institute (PSI) is holding a free webinar on Thursday, October 15th from 2-3:30pm EDT exploring how the 2014 DEA rule change has impacted pharmaceutical collection programs. What this webinar is about... When the DEA published its final rule last September, they expanded the number and types of entities that may be permitted to collect unwanted medications, making way for more numerous and convenient collection options for consumers. The rule allows manufacturers, distributors, reverse distributors, narcotics treatment programs, retail pharmacies, and hospitals/clinics with an on-site pharmacy to voluntarily apply for DEA authorization and maintain on-site drug collection receptacles and mail-back programs. It has been widely accepted that retail pharmacies would provide the most convenient location for unused drug collection to the broadest population. How have these retail sites put this new rule into action? What does it take to create and manage one of these programs? What challenges did they face in implementing collection sites? Do retailers benefit from having a collection site in their pharmacy? Our expert speakers will explore these questions and more on our upcoming webinar. There will be an extended Q&A session following the presentations. Speakers include... * Marcia Meuting, Pharm.D., R.P. | Nebraska DUR Director, Nebraska Pharmacists Association * Jan Harris | Director of Environmental Health & Safety, Sharps Compliance, Inc. * Dan King | Household Hazardous Waste Coordinator, Lincoln-Lancaster County Health Department, NE * Retail Representative | TBD * Scott Cassel | Chief Executive Officer and Founder, Product Stewardship Institute (Moderator) Register here for free. Thanks, Suzy Whalen _____________________________________ Suzy Whalen Outreach and Communications Coordinator Product Stewardship Institute, Inc. 29 Stanhope St., 3rd Floor, Boston, MA 02116 P: (617) 236-8293 F: (617) 236-4766 TTY: please dial 711. www.productstewardship.us suzy@productstewardship.us Follow our Facebook, Twitter and Blog -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150911/fa4ab4fa/attachment.htm -------------- next part -------------- A non-text attachment was scrubbed... Name: image001.png Type: image/png Size: 167 bytes Desc: image001.png Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150911/fa4ab4fa/image001.png From kategammon at gmail.com Fri Sep 11 14:49:40 2015 From: kategammon at gmail.com (Kate Gammon) Date: Fri Sep 11 14:53:44 2015 Subject: [Pharmwaste] Reporter looking for sources Message-ID: Greetings, I'm a freelance science writer working on a story for Chemical & Engineering News (a publication for chemists) about safe drug disposal programs -- especially regulations, programs, and the future. I've been trying to figure out the lay of the land in this area, and David Wihry pointed me to this list. If you'd be up for helping me out with my story, please drop me a line at kategammon@gmail.com. Thanks in advance, Kate Gammon ------------------------------- science writer santa monica, calif. http://www.katharinegammon.com -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150911/4f7db99d/attachment.htm From zenllc at usfamily.net Fri Sep 25 10:12:19 2015 From: zenllc at usfamily.net (Catherine Zimmer) Date: Fri Sep 25 10:12:46 2015 Subject: [Pharmwaste] pharm waste rules Message-ID: <002001d0f79c$346668f0$9d333ad0$@usfamily.net> Published in today's federal register: http://www.gpo.gov/fdsys/pkg/FR-2015-09-25/html/2015-23167.htm Enjoy! Very truly yours, Catherine Zimmer, MS, BSMT Zimmer Environmental Improvement, LLC Reducing and managing healthcare related waste and costs for fifteen years. St. Paul, MN Ph: 651.645.7509 zenllc@usfamily.net -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150925/b9d36390/attachment.html From Heidi at calpsc.org Sat Sep 26 12:59:17 2015 From: Heidi at calpsc.org (Heidi Sanborn) Date: Sat Sep 26 12:59:43 2015 Subject: [Pharmwaste] NEWS RELEASE: National Stewardship Action Council (NSAC) Forms to Promote a Circular Economy Through Producer Responsibility Message-ID: <24D2A3DBD4377240A1B613A8B5293DBD40DA90A3@MBX029-E1-VA-8.EXCH029.DOMAIN.LOCAL> [cid:37AB7722-3FCE-434E-915D-AB52E5E0B21E] For Immediate Release Contact: Bill Bradley September 25, 2015 (916) 213-5230 bill@me-comm.com NEW ADVOCACY ORGANIZATION LAUNCHES! National Stewardship Action Council (NSAC) Forms to Promote a Circular Economy Through Producer Responsibility The NSAC is a Collaboration of Partners Across the United States Advocating for Sensible and Effective Product Stewardship Policies (Sacramento, CA) - While countries around the world discuss and transition to a ?circular economy,? the concept is relatively new to the United States. The National Stewardship Action Council (NSAC) was created to push the U.S. in the direction of a circular economy, which is a generic term for an industrial economy that is, by design or intention, restorative and in which material flows are of two types, biological nutrients, designed to reenter the biosphere safely, and technical nutrients, which are designed to circulate at high quality without entering the biosphere. In short, a closed loop system where materials are all reused and recycled indefinitely. Doug Kobold, Vice Chair of the California Product Stewardship Council explains why a new organization was formed: ?With Extender Producer Responsibility (EPR) beginning to take hold on a national level, expertise in the drafting of laws governing EPR is greatly needed. NSAC, being born out of CPSC, in a state with the most EPR laws on the books today, stands poised to help stakeholders nationwide develop quality state and local laws that will be affordable, sensible, fair, effective, and enforceable. As President of NSAC, I am proud to be a part of this newly formed asset to the world of EPR and Product Stewardship.? The National Stewardship Action Council is a powerful network of governments, non-government organizations, businesses, and individuals advocating for policies and projects where producers share in the responsibility for funding and managing problem products at end of life. NSAC supports Extended Producer Responsibility (EPR) to conserve resources, reduce costs to local governments, create jobs in remanufacturing, and provide a circular economy. NSAC?s goal is to align public and private sectors through information and partnerships to implement and ensure sustainable recovery systems where producers have an appropriate level of sharing in the responsibility for those systems. One CPSC Board member resigned from the organization to become Secretary/Treasurer of NSAC: ?We need the ability to advocate for producers sharing responsibility and I am proud to be playing a part in the start of the organization that will do just that,? said Patty Garbarino of Marin Sanitary Service. ?I have been active for years trying to achieve zero waste, but we all know that until the products on the market are recyclable, there is only so much the waste management community can do to recycle and compost products designed for disposal.? ?I am very excited after eight years of leading CPSC to take that experience and move beyond primarily education about what producer responsibility means, to advocating nationally for this policy approach,? said Heidi Sanborn, Executive Director of NSAC. For more information, contact Heidi Sanborn at (916) 402-3911 or visit our website at www.NSAction.us About NSAC NSAC was founded in 2015 as an affiliate of the California Product Stewardship Council (CPSC). CPSC, which is a 501(c)(3) environmental education and protection organization under IRS rules, may only conduct limited legislative lobbying activities. CPSC?s recent legislative successes in California have come with increasing demands from across the country for CPSC?s assistance, creating the need for an entity that can carry CPSC?s work forward without lobbying limits, and on a national scale. In contrast to CPSC, NSAC is a 501(c)(4) nonprofit organization that will engage primarily in lobbying and advocacy work for EPR and Product Stewardship, anywhere in the U.S. and at any level of government interested in EPR legislation. NSAC will also be able to become involved in elections for public office, should such activities be needed to further its mission. NSAC?s Vision Be a catalyst to effect accountable, nation-wide, producer responsibility. NSAC?s Mission Producers have the primary responsibility to establish, fund, and manage end of life systems for their products with governmental entities setting the performance goals, ensuring accountability and transparency, and driving green design. NSAC is to achieve these goals through an organization of broad stakeholder partners from both public and private interests. -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150926/4dc2a07a/attachment-0001.html -------------- next part -------------- A non-text attachment was scrubbed... Name: 37AB7722-3FCE-434E-915D-AB52E5E0B21E.png Type: image/png Size: 76561 bytes Desc: 37AB7722-3FCE-434E-915D-AB52E5E0B21E.png Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150926/4dc2a07a/37AB7722-3FCE-434E-915D-AB52E5E0B21E-0001.png -------------- next part -------------- A non-text attachment was scrubbed... Name: NSAC Announcement Release 9-25-15 FINAL.pdf Type: application/pdf Size: 265980 bytes Desc: NSAC Announcement Release 9-25-15 FINAL.pdf Url : http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150926/4dc2a07a/NSACAnnouncementRelease9-25-15FINAL-0001.pdf From Laurie.Tenace at dep.state.fl.us Wed Sep 30 12:45:27 2015 From: Laurie.Tenace at dep.state.fl.us (Tenace, Laurie) Date: Wed Sep 30 12:45:39 2015 Subject: [Pharmwaste] FW: Public Webinars on 2 EPA Proposed Rules In-Reply-To: References: Message-ID: Please note that this email did not originate with me - Laurie From: Fitzgerald, Kristin [mailto:Fitzgerald.Kristin@epa.gov] Sent: Wednesday, September 30, 2015 10:32 AM Subject: Public Webinars on 2 EPA Proposed Rules EPA will host two public webinars to present the main provisions being proposed and to answer some questions on the proposal. The Hazardous Waste Pharmaceuticals Proposed Rule: Tuesday, October 13, 2015 from 2:00 to 3:30 EDT. Please register for the webinar at https://attendee.gotowebinar.com/register/7566815202467953154 The Hazardous Waste Generator Improvements Proposed Rule Thursday, October 15, 2015 from 2:00 to 3:30 EDT. Please register here at https://attendee.gotowebinar.com/register/2805554920732830978). ********************************************** Kristin Fitzgerald U.S. Environmental Protection Agency Office of Resource Conservation & Recovery Materials Recovery & Waste Management Division Recycling & Generator Branch phone: 703-308-8286 work schedule: Monday - Thursday Interested in learning which pharmaceuticals are hazardous waste? Visit the Hazardous Waste Pharmaceuticals Wiki: http:\\HWpharms.wikispaces.com -------------- next part -------------- An HTML attachment was scrubbed... URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20150930/e72acdc1/attachment.html